´ëÇÑ°£¾ÏÇÐȸ ILCA School of Liver Cancer : 2024-04-06
±³À°ÀÏÀÚ : 2024-04-06
±³À°Àå¼Ò : ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀǽÇ
±³À°ÁÖÁ¦ : ILCA School of Liver Cancer
ÁÖÃÖ±â°ü : ´ëÇÑ°£¾ÏÇÐȸ
´ã´çÀÚ : ¿ÀÀ±Àç ´ë¸®
¿¬¶ôó : 02-373-1005
À̸ÞÀÏ : klca@hbni.co.kr
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú
Âü¼®¿¹»óÀÎ : 70¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 300,000¿ø
ºñ°í ILCA member 200,000¿ø / Non member 300,000¿ø / Resident, Fellow, Trainee, Researcher 70,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 08:40~08:55 Exploring Tumor Microenvironment and Immunology in HCC Pil Soo Sung(The Catholic Univ. of Korea)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 08:55~09:10 The Oncogenomic Landscape in HCC Sun Young Yim(Korea Univ.)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 09:10~09:25 Pathological and Molecular Features of HCC and CCC Haeryoung Kim (Seoul National Univ.)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 09:25~09:40 Molecular Features and Classification of ICC and Combined HCC-CCC Hyun Goo Woo (Ajou Univ.)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 09:40~10:00 Meet the Professor and Speaker (Discussion with Q&A) Jessica Zucman-Rossi, Joong-Won Park, Young Nyun Park, Moon Seok Choi(Univ. Paris Descartes, France, Myongji Hospital, Hanyang Univ. , Yonsei Univ., Sungkyunkwan Univ.)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 10:00~10:15 What is the Best Option for Advanced HCC?: Second-Line and Sequential Therapy Bo Hyun Kim(National Cancer Center)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 10:15~10:30 Can We Predict Treatment Response in the Era of Immuno-Oncology? Do Young Kim (Yonsei Univ.)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 10:30~10:45 How to Expect and Manage the Adverse Events of Immunotherapy? Wonseok Kang (Sungkyunkwan Univ.)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 10:45~11:00 How to Boost TKI Efficacy in Advanced HCC with Combination Therapies Ju Hyun Shim (Univ. of Ulsan)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 11:00~11:20 Meet the Professor and Speaker (Discussion with Q&A) Tim Meyer, Jong Young Choi, Lorenza Rimassa, Ho Yeong Lim(Univ. College London, UK, The Catholic Univ. of Korea, Humanitas Univ., Italy, Sungkyunkwan Univ.)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 11:40~11:55 What are the Current and Future Trends in Imaging Diagnosis of HCC? So Yeon Kim(Univ. of Ulsan)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 11:55~12:10 Imaging-Based Prediction of Prognosis for HCC Seung Baek Hong (Pusan National Univ.)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 12:10~12:25 Surveillance and Post-Treatment Response Evaluation Eun Sun Jang (Seoul National Univ.)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 12:25~12:40 Optimal Medical Care to Improve Outcomes after HCC Treatment Sung Won Lee (The Catholic Univ. of Korea)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 13:40~13:55 Evolving Role of TACE in the Intermediate-Stage HCC: Good or Poor Responders? Dongho Hyun(Sungkyunkwan Univ.)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 13:55~14:10 Transarterial Radioembolization for HCC: Patient Selection and Assessment Hyo-Cheol Kim (Seoul National Univ.)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 14:10~14:25 Evolution of Radiotherapy for HCC: Balancing Tumor Control and Hepatic Function Preservation Sang Min Yoon(Univ. of Ulsan)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 14:25~14:40 Particle Beam Radiotherapy: Best Indications for HCC Tae Hyun Kim(National Cancer Center)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 14:40~14:55 Minimally Invasive Liver Resection for HCC and CCC Dong-Sik Kim(Korea Univ.)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 14:55~15:10 Liver Transplantation in HCC and CCC: Expanding Indications Dong Jin Joo (Yonsei Univ.)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 15:10~15:25 Clinical Decision in Borderline Lesions for Local Ablation Therapy Dong Ho Lee (Seoul National Univ.)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 15:25~15:40 Role of Local Ablation Therapy as a Bridge for Curative Therapy Joon-Il Choi (The Catholic Univ. of Korea)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 16:00~16:20 HCC with Intermediate Stage Jung Hee Kim (Hallym Univ.)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 16:20~16:40 HCC with Vascular Invasion Young-Sun Lee (Korea Univ.)
±³À°½Ã°£ 04¿ù 06ÀÏ ¼¿ï´ëÇб³(º´¿ø) ÀÇ°ú´ëÇÐ À¶ÇÕ°ü 1Ãþ Çлý°ÀÇ½Ç 16:40~17:00 HCC with Metastasis Sangyoun Hwang(Dongnam Inst. of Radiological £¦ Medical Sciences)